+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Polyclonal Antibodies"

Polyclonal Antibodies Market Report 2025 - Product Thumbnail Image

Polyclonal Antibodies Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
Antibodies Market Report 2024 - Product Thumbnail Image

Antibodies Market Report 2024

  • Report
  • December 2024
  • 175 Pages
  • Global
From
Research Antibodies - Global Strategic Business Report - Product Thumbnail Image

Research Antibodies - Global Strategic Business Report

  • Report
  • March 2025
  • 93 Pages
  • Global
From
From
From
Research Antibodies Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Research Antibodies Market - Forecasts from 2024 to 2029

  • Report
  • May 2024
  • 124 Pages
  • Global
From
From
From
From
Research Antibodies Market - Product Thumbnail Image

Research Antibodies Market

  • Report
  • January 2024
  • 485 Pages
  • Global
From
Loading Indicator

Polyclonal antibodies are a type of immune disorder drug used to treat a variety of conditions, including autoimmune diseases, allergies, and cancer. These drugs are made up of a mixture of antibodies that are produced by the body in response to a foreign substance, such as a virus or bacteria. They work by targeting and neutralizing the foreign substance, thus preventing it from causing further damage. Polyclonal antibodies can be administered intravenously, intramuscularly, or subcutaneously. Polyclonal antibodies are used to treat a variety of conditions, including rheumatoid arthritis, multiple sclerosis, Crohn's disease, and psoriasis. They are also used to treat certain types of cancer, such as lymphoma and leukemia. In addition, polyclonal antibodies are used to treat allergies, such as hay fever and asthma. The polyclonal antibodies market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more